Development and evaluation of a monolithic floating drug delivery system for acyclovir

Chemical and Pharmaceutical Bulletin

Volumn 60, Issue 2, 2012, Pages 172-177

  Tavakoli, Naser ^a   Varshosaz, Jaleh ^a   Dorkoosh, Farid ^b   Motaghi, Sedigheh ^a   Tamaddon, Lana ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acyclovir; Floating drug delivery system; Gastric residence time

Indexed keywords

ACICLOVIR; ALGINIC ACID; BICARBONATE; CARBOMER; CITRIC ACID; HYDROCHLORIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; POVIDONE;

ARTICLE; CHEMICAL COMPOSITION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; DRUG SOLUBILITY; EFFERVESCENT TABLET; FLOATING DRUG DELIVERY SYSTEM; MUCOADHESION; PHYSICAL CHEMISTRY; TABLET COMPRESSION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET MATRIX;

ACYCLOVIR; ANTIVIRAL AGENTS; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; TABLETS;

EID: 84856566026     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.60.172     Document Type: Article

References (28)

1. Sauzet C., Claeys-Bruno M., Nicolas M., Kister J., Piccerelle P., Prinderre P., Int. J. Pharm., 378, 23-29 (2009).
2. Garg R., Gupta G. D., Trop. J. Pharm. Res., 7, 1055-1066 (2008).
3. Tadros M. I., Eur. J. Pharm. Biopharm., 74, 332-339 (2010).
4. Singh B. N., Kim K. H., J. Controlled Release, 63, 235-259 (2000).
5. Sweetman S. C., "Martindale, The Complete Drug Reference," 36th ed., The Pharmaceutical Press, London, 2009, pp. 862-865.
6. Tao Y., Lu Y., Sun Y., Gu B., Lu W., Pan J., Int. J. Pharm., 378, 30-36 (2009).
7. Fuertes I., Miranda A., Millán M., Caraballo I., Eur. J. Pharm. Biopharm., 64, 336-342 (2006).
8. Stulzer H. K., Lacerda L., Tagliari M. P., Silva M. A. S., Favere V. T., Laranjeira M. C. M., Carbohydr. Polym., 73, 490-497 (2008).
9. Rossi S., Sandri G., Ferrari F., Bonferoni M. C., Caramella C., Pharm. Dev. Technol., 8, 199-208 (2003).
10. Dhaliwal S., Jain S., Singh H. P., Tiwary A. K., AAPS J., 10, 322-330 (2008).
11. Junyaprasert V. B., Pornsuwannapha S., Drug Deliv., 15, 331-341 (2008).
12. Tavakoli N., Varshosaz J., Dorkoosh F., Rezazadeh A., Pharmaceutical Science, 4, 7-14 (2007).
13. "The United States, Pharmacopeia-National Formulary (USP31-NF26)," The United Pharmacopial Convention, Inc., Washington, 2008, pp. 1303-1306.
14. Korsmeyer R. W., Gurny R., Doelker E., Buri P., Peppas N. A., Int. J. Pharm., 15, 25-35 (1983).
15. Khan K. A., Rhodes C. T., J. Pharm. Pharmacol., 27, 48-49 (1975).
16. Goole J., Deleuze P., Vanderbist F., Amighi K., Eur. J. Pharm. Biopharm., 68, 310-318 (2008).
17. Streubel A., Siepmann J., Bodmeier R., Eur. J. Pharm. Sci., 18, 37-45 (2003).
18. Rowe R. C., Sheskey P. J., Quinn M. E., "Handbook of Pharmaceutical Excipient," 6th ed., Pharmaceutical Press, London, 2009, pp. 581-585.
19. Xu X., Sun M., Zhi F., Hu Y., Int. J. Pharm., 310, 139-145 (2006).
20. Chen R. N., Ho H. O., Yu C. Y., Sheu M. T., Eur. J. Pharm. Sci., 39, 82-89 (2010).
21. Li S., Lin S., Daggy B. P., Mirchandani H. L., Chien Y. W., Int. J. Pharm., 253, 13-22 (2003).
22. Marcos B. P., Ford J. L., Armstrong D. J., Elliott P. N. C., Rostron C., Hogan J. E., Int. J. Pharm., 111, 251-259 (1994).
23. Chavanpatil M. D., Jain P., Chaudhari S., Shear R., Vavia P. R., Int. J. Pharm., 316, 86-92 (2006).
24. Karasulu E., Yeşim Karasulu H., Ertan G., Kirilmaz L., Güneri T., Eur. J. Pharm. Sci., 19, 99-104 (2003).
25. Siepmann J., Peppas N. A., Adv. Drug Deliv. Rev., 48, 139-157 (2001).
26. Korsmeyer R. W., Gumy R., Doelker E., Buri P., Peppas N. A., Int. J. Pharm., 15, 23-35 (1983).
27. Attia M. A., EI-Gibaly I., Shaltout S. E., Fetih G. N., Int. J. Pharm., 276, 11-28 (2004).
28. Patel V. F., Liu F., Brown M. B., J. Controlled Release, 153, 106-116 (2011).